机器学习应用于分类和监测埃塞俄比亚2型糖尿病患者的药物依从性。

IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Frontiers in Endocrinology Pub Date : 2025-03-20 eCollection Date: 2025-01-01 DOI:10.3389/fendo.2025.1486350
Ewunate Assaye Kassaw, Ashenafi Kibret Sendekie, Bekele Mulat Enyew, Biruk Beletew Abate
{"title":"机器学习应用于分类和监测埃塞俄比亚2型糖尿病患者的药物依从性。","authors":"Ewunate Assaye Kassaw, Ashenafi Kibret Sendekie, Bekele Mulat Enyew, Biruk Beletew Abate","doi":"10.3389/fendo.2025.1486350","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medication adherence plays a crucial role in determining the health outcomes of patients, particularly those with chronic conditions like type 2 diabetes. Despite its significance, there is limited evidence regarding the use of machine learning (ML) algorithms to predict medication adherence within the Ethiopian population. The primary objective of this study was to develop and evaluate ML models designed to classify and monitor medication adherence levels among patients with type 2 diabetes in Ethiopia, to improve patient care and health outcomes.</p><p><strong>Methods: </strong>Using a random sampling technique in a cross-sectional study, we obtained data from 403 patients with type 2 diabetes at the University of Gondar Comprehensive Specialized Hospital (UoGCSH), excluding 13 subjects who were unable to respond and 6 with incomplete data from an initial cohort of 422. Medication adherence was assessed using the General Medication Adherence Scale (GMAS), an eleven-item Likert scale questionnaire. The responses served as features to train and test machine learning (ML) models. To address data imbalance, the Synthetic Minority Over-sampling Technique (SMOTE) was applied. The dataset was split using stratified K-fold cross-validation to preserve the distribution of adherence levels. Eight widely used ML algorithms were employed to develop the models, and their performance was evaluated using metrics such as accuracy, precision, recall, and F1 score. The best-performing model was subsequently deployed for further analysis.</p><p><strong>Results: </strong>Out of 422 enrolled patients, 403 data samples were collected, with 11 features extracted from each respondent. To mitigate potential class imbalance, the dataset was increased to 620 samples using the Synthetic Minority Over-sampling Technique (SMOTE). Machine learning models including Logistic Regression (LR), Support Vector Machine (SVM), K Nearest Neighbor (KNN), Decision Tree (DT), Random Forest (RF), Gradient Boost Classifier (GBC), Multilayer Perceptron (MLP), and 1D Convolutional Neural Network (1DCNN) were developed and evaluated. Although the performance differences among the models were subtle (within a range of 0.001), the SVM classifier outperformed the others, achieving a recall of 0.9979 and an AUC of 0.9998. Consequently, the SVM model was selected for deployment to monitor and detect patients' medication adherence levels, enabling timely interventions to improve patient outcomes.</p><p><strong>Conclusions: </strong>This study highlights a variety of machine learning (ML) models that can be effectively used to monitor and classify medication adherence in diabetic patients in Ethiopia. However, to fully realize the potential impact of digital health applications, further studies that include patients from diverse settings are necessary. Such research could enhance the generalizability of these models and provide insights into the broader applicability of digital tools for improving medication adherence and patient outcomes in varying healthcare contexts.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1486350"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965118/pdf/","citationCount":"0","resultStr":"{\"title\":\"Machine learning applications to classify and monitor medication adherence in patients with type 2 diabetes in Ethiopia.\",\"authors\":\"Ewunate Assaye Kassaw, Ashenafi Kibret Sendekie, Bekele Mulat Enyew, Biruk Beletew Abate\",\"doi\":\"10.3389/fendo.2025.1486350\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Medication adherence plays a crucial role in determining the health outcomes of patients, particularly those with chronic conditions like type 2 diabetes. Despite its significance, there is limited evidence regarding the use of machine learning (ML) algorithms to predict medication adherence within the Ethiopian population. The primary objective of this study was to develop and evaluate ML models designed to classify and monitor medication adherence levels among patients with type 2 diabetes in Ethiopia, to improve patient care and health outcomes.</p><p><strong>Methods: </strong>Using a random sampling technique in a cross-sectional study, we obtained data from 403 patients with type 2 diabetes at the University of Gondar Comprehensive Specialized Hospital (UoGCSH), excluding 13 subjects who were unable to respond and 6 with incomplete data from an initial cohort of 422. Medication adherence was assessed using the General Medication Adherence Scale (GMAS), an eleven-item Likert scale questionnaire. The responses served as features to train and test machine learning (ML) models. To address data imbalance, the Synthetic Minority Over-sampling Technique (SMOTE) was applied. The dataset was split using stratified K-fold cross-validation to preserve the distribution of adherence levels. Eight widely used ML algorithms were employed to develop the models, and their performance was evaluated using metrics such as accuracy, precision, recall, and F1 score. The best-performing model was subsequently deployed for further analysis.</p><p><strong>Results: </strong>Out of 422 enrolled patients, 403 data samples were collected, with 11 features extracted from each respondent. To mitigate potential class imbalance, the dataset was increased to 620 samples using the Synthetic Minority Over-sampling Technique (SMOTE). Machine learning models including Logistic Regression (LR), Support Vector Machine (SVM), K Nearest Neighbor (KNN), Decision Tree (DT), Random Forest (RF), Gradient Boost Classifier (GBC), Multilayer Perceptron (MLP), and 1D Convolutional Neural Network (1DCNN) were developed and evaluated. Although the performance differences among the models were subtle (within a range of 0.001), the SVM classifier outperformed the others, achieving a recall of 0.9979 and an AUC of 0.9998. Consequently, the SVM model was selected for deployment to monitor and detect patients' medication adherence levels, enabling timely interventions to improve patient outcomes.</p><p><strong>Conclusions: </strong>This study highlights a variety of machine learning (ML) models that can be effectively used to monitor and classify medication adherence in diabetic patients in Ethiopia. However, to fully realize the potential impact of digital health applications, further studies that include patients from diverse settings are necessary. Such research could enhance the generalizability of these models and provide insights into the broader applicability of digital tools for improving medication adherence and patient outcomes in varying healthcare contexts.</p>\",\"PeriodicalId\":12447,\"journal\":{\"name\":\"Frontiers in Endocrinology\",\"volume\":\"16 \",\"pages\":\"1486350\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965118/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fendo.2025.1486350\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fendo.2025.1486350","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:药物依从性在决定患者的健康结果方面起着至关重要的作用,特别是那些患有2型糖尿病等慢性疾病的患者。尽管其意义重大,但关于使用机器学习(ML)算法来预测埃塞俄比亚人口的药物依从性的证据有限。本研究的主要目的是开发和评估用于分类和监测埃塞俄比亚2型糖尿病患者药物依从性水平的ML模型,以改善患者护理和健康结果。方法:采用横断面研究的随机抽样技术,我们从贡达尔大学综合专科医院(UoGCSH)获得403例2型糖尿病患者的数据,从422名初始队列中排除了13名无应答者和6名数据不完整者。药物依从性评估采用一般药物依从性量表(GMAS),一个11项李克特量表问卷。这些响应被用作训练和测试机器学习(ML)模型的特征。为了解决数据不平衡问题,采用了合成少数派过采样技术(SMOTE)。使用分层k折交叉验证对数据集进行分割,以保留依从性水平的分布。采用了8种广泛使用的ML算法来开发模型,并使用准确性、精密度、召回率和F1分数等指标来评估它们的性能。随后部署性能最好的模型进行进一步分析。结果:在422例入组患者中,收集了403个数据样本,从每个应答者中提取了11个特征。为了减轻潜在的类不平衡,使用合成少数过度抽样技术(SMOTE)将数据集增加到620个样本。机器学习模型包括逻辑回归(LR)、支持向量机(SVM)、K近邻(KNN)、决策树(DT)、随机森林(RF)、梯度增强分类器(GBC)、多层感知器(MLP)和一维卷积神经网络(1DCNN)。虽然模型之间的性能差异很小(在0.001范围内),但SVM分类器的性能优于其他分类器,实现了0.9979的召回率和0.9998的AUC。因此,选择SVM模型进行部署,以监测和检测患者的药物依从性水平,及时干预以改善患者预后。结论:本研究强调了各种机器学习(ML)模型,可以有效地用于监测和分类埃塞俄比亚糖尿病患者的药物依从性。然而,为了充分认识数字健康应用的潜在影响,有必要对来自不同环境的患者进行进一步的研究。此类研究可以增强这些模型的普遍性,并为数字工具在不同医疗保健环境中改善药物依从性和患者预后的更广泛适用性提供见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Machine learning applications to classify and monitor medication adherence in patients with type 2 diabetes in Ethiopia.

Background: Medication adherence plays a crucial role in determining the health outcomes of patients, particularly those with chronic conditions like type 2 diabetes. Despite its significance, there is limited evidence regarding the use of machine learning (ML) algorithms to predict medication adherence within the Ethiopian population. The primary objective of this study was to develop and evaluate ML models designed to classify and monitor medication adherence levels among patients with type 2 diabetes in Ethiopia, to improve patient care and health outcomes.

Methods: Using a random sampling technique in a cross-sectional study, we obtained data from 403 patients with type 2 diabetes at the University of Gondar Comprehensive Specialized Hospital (UoGCSH), excluding 13 subjects who were unable to respond and 6 with incomplete data from an initial cohort of 422. Medication adherence was assessed using the General Medication Adherence Scale (GMAS), an eleven-item Likert scale questionnaire. The responses served as features to train and test machine learning (ML) models. To address data imbalance, the Synthetic Minority Over-sampling Technique (SMOTE) was applied. The dataset was split using stratified K-fold cross-validation to preserve the distribution of adherence levels. Eight widely used ML algorithms were employed to develop the models, and their performance was evaluated using metrics such as accuracy, precision, recall, and F1 score. The best-performing model was subsequently deployed for further analysis.

Results: Out of 422 enrolled patients, 403 data samples were collected, with 11 features extracted from each respondent. To mitigate potential class imbalance, the dataset was increased to 620 samples using the Synthetic Minority Over-sampling Technique (SMOTE). Machine learning models including Logistic Regression (LR), Support Vector Machine (SVM), K Nearest Neighbor (KNN), Decision Tree (DT), Random Forest (RF), Gradient Boost Classifier (GBC), Multilayer Perceptron (MLP), and 1D Convolutional Neural Network (1DCNN) were developed and evaluated. Although the performance differences among the models were subtle (within a range of 0.001), the SVM classifier outperformed the others, achieving a recall of 0.9979 and an AUC of 0.9998. Consequently, the SVM model was selected for deployment to monitor and detect patients' medication adherence levels, enabling timely interventions to improve patient outcomes.

Conclusions: This study highlights a variety of machine learning (ML) models that can be effectively used to monitor and classify medication adherence in diabetic patients in Ethiopia. However, to fully realize the potential impact of digital health applications, further studies that include patients from diverse settings are necessary. Such research could enhance the generalizability of these models and provide insights into the broader applicability of digital tools for improving medication adherence and patient outcomes in varying healthcare contexts.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Endocrinology
Frontiers in Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.70
自引率
9.60%
发文量
3023
审稿时长
14 weeks
期刊介绍: Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series. In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology. Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信